Disclosures. Not as Pink as You Think 3/17/2014. Not As Pink As You Think: Pulse Oximetry Screening For Critical Congenital Heart Disease



Similar documents
Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn

Critical Congenital Heart Disease (CCHD) Screening

Toolkit for Implementation of Pulse Oximetry Screening for Critical Congenital Heart Disease

Cardiovascular Pathophysiology:

Working Towards Neonatal Pulse Oximetry Screening to Detect Critical CHD

The Heart Center Neonatology. Congenital Heart Disease Screening Program

Pulse Oximetry Screening for Congenital Heart Disease: Toolkit

Feeding in Infants with Complex Congenital Heart Disease. Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014

Universal Fetal Cardiac Ultrasound At the Heart of Newborn Well-being

The Pattern of Congenital Heart Disease among Neonates Referred for Echocardiography

Workshop B: Essentials of Neonatal Cardiology and CHD Anthony C. Chang, MD, MBA, MPH CARDIAC INTENSIVE CARE

The Patterns and Public Health Impact of Heart Defects in Texas Pediatric Cardiac Care Conference VI Dell Children s Medical Center, Feb.

Facts about Congenital Heart Defects

How to get insurance companies to work with you

Delivery Planning for the Fetus with Congenital Heart Disease

Common types of congenital heart defects

Fiscal Note Screening for Critical Congenital Heart Defects. Department of Health and Human Services, Division of Public Health

Pulmonary Atresia With Intact Ventricular Septum - Anatomy, Physiology, and Diagnostic Imaging

NICU Reporting. Alyssa Yang CDC/CSTE Applied Epidemiology Fellow February 28, 2014

From Children s National Medical Center. Congenital Heart Disease Screening Program Toolkit: A Toolkit for Implementing Screening.

CCHD Screening in Maryland - Year 1 Results APHL NBSGTS Meeting October 29, 2014, Anaheim CA

December 9, RE: Critical Congenital Heart Disease (CCHD) Screening. Dear Alaskan Healthcare Provider:

Current status of pediatric cardiac surgery

CONGENITAL HEART DISEASE

Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects

Screening for Critical Congenital Heart Disease in Newborns Using Pulse Oximetry

Congenital Heart Defects Initial Diagnosis and

Cardiology Fellowship Manual. Goals & Objectives -Cardiac Imaging- 1 Page

Screening for Congenital Heart Defects

Congenital Diaphragmatic Hernia By Dr. N. Robert Payne

Screening for Critical Congenital Heart Disease in Newborns Using Pulse Oximetry Role for a Birth Defect Registry

Requirements for Provision of Outreach Paediatric Cardiology Service

Questions FOETAL CIRCULATION ANAESTHESIA TUTORIAL OF THE WEEK TH MAY 2008

Results From the New Jersey Statewide Critical Congenital Heart Defects Screening Program

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire

Prenatal Diagnosis of Congenital Heart Disease

echocardiography practice and try to determine the ability of each primary indication to identify congenital heart disease. Patients and Methods

Newborn Screening and Health Information Technology

Congenital heart defects

Why is prematurity a concern?

BIRTH DEFECTS IN MICHIGAN All Cases Reported and Processed by April 15, 2008

Seemingly healthy newborn babies may be admitted to the nursery with hidden

HEART MURMURS THROUGHOUT CHILDHOOD

Congenital Diaphragmatic Hernia. Manuel A. Molina, M.D. University Hospital at Brooklyn SUNY Downstate

Regions Hospital Delineation of Privileges Nurse Practitioner

Newborn Screening for Critical Congenital Heart Disease: Essential Public Health Roles for Birth Defects Monitoring Programs

Nutrition in Paediatric Cardiology. Karen Hayes Paediatric Dietitian Addenbrooke s Hospital

Newborn outcomes after cesarean section for fetal distress in BC


A8b. Resuscitation of a Term Infant with Meconium Staining. Session Summary. Session Objectives. References

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

HEART DISEASE IN THE YOUNG CHARLES S. KLEINMAN, M.D.

Anesthesia in Children with Congenital Heart Disease. Elliot Krane, M.D.

Safe Zone: CV PIP < 26; HFOV: MAP < 16; HFJV: MAP < 16 Dopamine infusion up to 20 mcg/kg/min Epinephrine infusion up to 0.1 mcg /kg/min.

Chromosome Syndromes associated with Congenital Heart Defects

NHS FORTH VALLEY Neonatal Oxygen Saturation Guideline

Population prevalence rates of birth defects: a data management and epidemiological perspective

Health Policy Advisory Committee on Technology

25 Anomalies and Diseases of the Fetal Heart

The Newborn With a Congenital Disorder. Chapter 14. Copyright 2008 Wolters Kluwer Health Lippincott Williams & Wilkins

SMANN News! Volume 24 Issue 1

NPCNA 2015 Summer Newsletter

THE MARY ALLEN ENGLE, MD ( ) PAPERS

Chapter 2 Cardiac Interpretation of Pediatric Chest X-Ray

Lorissa R. Heath RN, MSN, APRN 32 Macintosh Way Southington, CT (860) (H) (860) (Fax)

2008 Coding Questions and Answers

CALIFORNIA CHILDREN S SERVICES MANUAL OF PROCEDURES 3.42 STANDARDS FOR INFANT HEARING SCREENING SERVICES

Use of Telemedicine Applications between Continents

More detailed background information and references can be found at the end of this guideline

Fetal Acid Base Status and Umbilical Cord Sampling. David Acker, MD

Congenital heart disease statistics

ROUTINE HEART EXAM AND

Social Security Administration Compassionate Allowances Outreach Hearing on Cardiovascular Disease and Multiple Organ Transplants November 9, 2010

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates

Question 1: Interpret the rhythm strip above (comment on regularity, rate, P wave, PR interval and QRS)?

Pattern of Congenital Heart Disease in Infants of Diabetic Mother

Fetal and neonatal mortality in patients with isolated congenital heart diseases and heart conditions associated with extracardiac abnormalities

Careful collection, organization and review of medical information

Pediatric Congenital Cardiac Surgery

Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis

NRP 2012 Putting New Resuscitation Guidelines into Practice

Congenital heart disease means that there is an abnormality. of the heart which has been present since birth. It occurs in

Michigan Pulse Oximetry Screening for Critical Congenital Heart Disease

ELSO GUIDELINES FOR ECMO CENTERS

APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Presentation of Congenital Heart Disease in the Neonate and Young Infant

Addendum to the NRP Provider Textbook 6 th Edition Recommendations for specific modifications in the Canadian context

Abnormal cardiac finding in prenatal sonographic examination: an important indication for fetal echocardiography?

NEONATAL CLINICAL PRACTICE GUIDELINE

Reinsurance for Early Retirees Program

North Dakota Birth Defects Monitoring System

Date of Birth Contact No Occupation

LEGISLATION. Maryland CCHD Screening AMCHP Annual Conference Washington DC 02/12/13 1/30/2013 THE JOURNEY BEGINS

CPT Pediatric Coding Updates The 2009 Current Procedural Terminology (CPT) codes are effective as of January 1, 2009.

Rural Health Advisory Committee s Rural Obstetric Services Work Group

Newborn Screening Update for Health Care Practitioners

Definitions. Child LifeAdvance. Critical Illness Insurance Plan

First Trimester Screening for Down Syndrome

PedsCases Podcast Scripts. Developed by Amarjot Padda, Chris Novak, Dr. Melanie Lewis and Dr. Bryan Dicken for

Transcription:

March of Dimes New York State Chapter 36th Annual Perinatal Nurses Conference Promoting Perinatal Health Through Evidence Based Practice Not As Pink As You Think: Pulse Oximetry Screening For Critical Congenital Heart Disease Robert Koppel, MD March 24, 2014 Disclosures Dr. Koppel has nothing to disclose. Not as Pink as You Think 1

Congenital Heart Disease 9/1,000 live births Approximately one quarter of these children will have critical congenital heart disease requiring surgery or catheter intervention in the first year of life Congenital Heart Disease Surgery allows for repair or palliation of nearly all congenital heart malformations Surgery and catheter interventions have resulted in a marked improvement in survival Surgery is often performed in the first weeks of life optimize hemodynamics prevent end organ injury timely diagnosis of CCHD can improve outcome for this population Window of opportunity for detection of critical congenital heart disease Newborn Nursery 2

Newborn Screening New York 1960s The Cyanotic Blind Spot Hokanson, Neonatology Today 2010;5(12):1-6. Morbidity Due to Delayed Diagnosis Shock global hypoxemic injury with multi organ dysfunction Hypotension Poor ventricular function Myocardial ischemia Pulmonary hypertension Renal dysfunction Hepatic dysfunction Decreased intestinal blood flow > NEC DIC Metabolic Hypoglycemia Hypocalcemia Myoglobinuria hypoxic ischemic encephalopathy 3

Fetal U/S Echocardiography fewer than 50% of cases are identified Best detection rate for single ventricle anatomy fewer than 30% detection of lesions with twoventricle anatomy Early Reports on Pulse Oximetry Screening Byrne, et al Identified in a population of 3896 consecutive asymptomatic newborns HLHS 1 Coarctation 1 Tetralogy of Fallot 1 Ped Res 1995, 37:198A Early Reports on Pulse Oximetry Screening Kao, et al: Using a cutoff of 95% 81% of infants with known critical congenital heart disease could be identified. Not effective at detecting aortic stenosis and coarctation Pediatr Res. 1995;37:216A 4

Method At time of dry blood spot collection, a reusable pulse oximeter probe is applied to the baby s foot Method When a steady wave form is displayed, the saturation is recorded Physician is notified for lower extremity saturation < 95% Pre and post ductal saturations are performed Echocardiogram is requested 5

LIJ Patient Diagnosis Detection 1 HLHS Fetal echocardiography 2 PA VSD Fetal echocardiography 3 Ebstein s Fetal echocardiography 4 HLHS Fetal echocardiography 5 PS Fetal echocardiography 6 ToF Fetal echocardiography 7 HLHS Fetal echocardiography 8 CoA Fetal echocardiography 9 IAA Fetal echocardiography 10 D TGA Cyanosis 11 Ebstein s Respiratory distress 12 D TGA Cyanosis 13 CoA Tachypnea/murmur 14 Truncus arteriosus Screening (SpO 2 86%) GSH Patient Diagnosis Detection 15 D TGA Cyanosis 16 PA Cyanosis 17 TAPVR Screening (SpO 2 92%) 18 TAPVR Screening (SpO 2 88%) Born at Hospitals Without Screening Patient Diagnosis Detection 19 CoA CHF, shock 20 HLHS Cyanosis, shock 21 ToF murmur False Negative Screen Patient Diagnosis Detection 22 CoA CHF 23 Hypoplastic LPA/AP collaterals Poor feeding, murmur 6

CCHD Hypothyroidism PKU Hearing Loss Frequency/ 44 25 7 260 100,000 births # positive, first 4 600 5 3500 screen # children 3 15 4 140 diagnosed PPV 75% 3% 80% 5% Cost of initial negligible $3 $3 $25 screen/child Screening cost/confirmed diagnosis negligible $10,800 $40,500 $9,860 Clinical result of delayed diagnosis Death CNS injury Cretinism Mental retardation Language, academic, and cognitive delays, psychosocial difficulties Circulation 2009;120;447-458; originally published online Jul 6, 2009 Pediatrics 2009;124;823-836; originally published online Jul 6, 2009 Clinical Studies of Pulse Oximetry Compilation of published studies Sensitivity 69.6% Specificity 99.9% Concerns about false positive rate and unnecessary echocardiograms After 24 hours, false positive rate 0.035% (~ 1/3000) 7

Detection of CCHD Lesions (SpO 2 < 95%) CCHD Lesion Total Percent Detected DORV 3/3 100 HLHS 5/5 100 PA 5/5 100 d TGA 9/9 100 TAPVC 6/7 85.7 Truncus 7/8 87.5 TA 1/1 100 AA/AS 3/4 75.0 TOF 9/13 69.2 AVSD 4/5 80.0 CoA 8/15 53.3 PS 2/6 33.3 Limitations of Oximetry Screening Less efficient at identifying left heart obstructive lesions limits the usefulness of oximetry as a screening tool Other types of lesions also result in morbidity/mortality All cases of HLHS were detected Coarctation detected in just over half of cases Limitations of Oximetry Screening Programmatic limitations Need for echocardiography Community hospitals Rural hospitals Solution Telemedicine 8

CCHD 7 The seven defects classified as CCHD are: 1. Hypoplastic Left Heart Syndrome (HLHS) 2. Pulmonary Atresia with intact septum (PA/IVS) 3. Tetralogy of Fallot (TOF) 4. Total Anomalous Pulmonary Venous Return (TAPVR) 5. Transposition of the Great Arteries (TGA) 6. Tricuspid Atresia (TA) 7. Truncus Arteriosus communis (TAC) SACHDNC Summary Pediatrics August 22, 2011 A significant body of evidence suggests that early detection of CCHD through pulse oximetry screening is an effective strategy for reducing morbidity and mortality in young children. The workgroup identified strategies for hospitals and birthing centers to implement pulse oximetry screening 9

SACHDNC Summary Pediatrics August 22, 2011 Screening should be conducted using motiontolerant pulse oximeters that report functional oxygen saturation cleared by the FDA for use in neonates SACHDNC Summary Pediatrics August 22, 2011 Screening in well baby and intermediate care nurseries should be based on the recommended screening algorithm, and be performed by any qualified health care personnel who have met training requirements (e.g., nurses, allied health technicians) SACHDNC Summary Pediatrics August 22, 2011 Any abnormal pulse oximetry screen requires a complete clinical evaluation by a licensed, independent practitioner. In the absence of other findings to explain hypoxemia, CCHD needs to be excluded, based on a comprehensive echocardiogram interpreted by a pediatric cardiologist before discharge to home. If an echocardiogram cannot be performed in the hospital or birthing center and diagnosis by telemedicine is not possible, strong consideration should be made for transfer to another medical center for diagnosis. Before implementing screening, protocols for arranging diagnostic follow up should be established. 10

AAP-AHA-CDC-HRSA The Lancet Volume 379, Issue 9835. 2459-2464, 30 June 2012 11

Hospitalizations, Costs, and Mortality Florida 1998 2007 2,128,236 live births in hospitals 3603 with CCHD 825 (23%) detected late 52% more hospital admissions 18% more hospital days 35% more inpatient costs Birth Defects Research (Part A): Clinical and Molecular Teratology DOI: 10.1002/bdra.23165 Cost Effectiveness of Routine Screening for CCHD in US Newborns Mathematical models based on Florida 1998 2007 1189 more newborns with timely CCHD detection 20 deaths averted by screening 1975 false positive results minimal impact on total estimated program costs Additional cost of $6.28 per newborn $20,862 per newborn with CCHD detected by screening $40,385 per life year gained per newborn with CCHD detected by screening Pediatrics 2013;132:1-9 CCHD < 28 days ED/PICU Transport no screening at birth hospital CCMC 2008 2012 Coarctation 10 Tetralogy of Fallot 3 TAPVR 2 Interrupted arch 2 HLHS 2 Aortic stenosis 1 Pulmonary atresia 1 Pulmonary stenosis 1 Tricuspid atresia 1 Ebstein s anomaly 1 12

Case Presentation 40 weeks gestation, C/S, 3600 grams Discharged home on day 3 Day 5: returned to ED for poor feeding and decreased activity SpO 2 : 80% ABG: ph 6.8 Echo: HLHS Pre op stabilization X 5 days Norwood stage I Post op ECMO X 8 days 2012 2014 www.cchdscreeningmap.org Case Presentation 39 weeks, NSVD, Apgar 9/9 Discharged home on Day 2 Oximetry screening post ductal SpO2 100% Day 3 Lethargy Decreased PO intake Dry diapers Tachypnea Evaluated by pediatrician 13

Case Presentation Referral to ED for respiratory distress grunting Retracting unable to measure SpO2 Intubated Umbilical arterial and venous catheters inserted Case Presentation ABG: 7.09/17/199/8/ 23.3 Chemistry: 143/8/104/6/63/5.98 Echo: coarctation, DA closed (history of normal fetal echo) Prostaglandin infusion Dialysis prior to CoA repair Swiss Cheese Model of Accident Causation British Medical Journal 320 (7237): 768 770 14

Swiss Cheese Model of CCHD Screening Failure Swiss Cheese Model of Accident Causation Obstetric ultrasound Fetal echo Newborn physical exam Nursery course Oximetry screening British Medical Journal 320 (7237): 768 770 Technical Factors False positive and negative readings Poor perfusion Motion artifact Ambient light Partial probe detachment Differences between manufacturers Pediatr Cardiol (2008) 29:885-889 15

Human Factors Phase I fewer than half of readings reliable Phase II 60% of readings reliable Improved reliability correlated with Higher level nursing degree LPN or higher Amount of time spent > 360 seconds Pediatr Cardiol (2008) 29:885-889 Accuracy: Paper Algorithm v. Computer Based Tool J Pediatr. 2014 Jan;164(1):67-71.e2. doi: 10.1016/j.jpeds.2013.08.044. Ease of Use: Paper Algorithm v. Computer Based Tool J Pediatr. 2014 Jan;164(1):67-71.e2. doi: 10.1016/j.jpeds.2013.08.044. 16

17

Helpful Hints Neonatal probe specific to oximeter Do not use adult probe Follow manufacturer s instructions Clean probe (re usable or single use) Apply to clean skin Best sites: palm and foot Light source and sensor directly opposite Preferably awake, calm, and quiet baby Avoid extraneous light Ideal CCHD Screening Program Education Nurses Normal newborn NICU Formal screener training Competency Continuing education Physicians Pediatricians Neonatologists Cardiologists Continuing education 18

Ideal CCHD Screening Program Education Parents Negative screen Positive screen languages Literacy Ideal CCHD Screening Program Standardization of algorithm Minimize variation Equipment Supplies Ideal CCHD Screening Program Universal testing Quality of Process Database Local Public health 19

Ideal CCHD Screening Program Documentation Automatic link to EHR Automatic reporting to DOH Ideal CCHD Screening Program Communication Parents Pediatrician Cardiologist 20